Drug discontinuation in pregnant women with psoriasis: The PSO-MOTHER cohort study.

Valeria BelleudiFrancesca R PoggiSerena PernaLuigi NaldiRenata BortolusAlessandro C RosaUrsula KirchmayerMarina DavoliAntonio Addis

Published in: Pharmacoepidemiology and drug safety (2020)

Majority of drugs come with warnings regarding potential embryo-fetotoxicity, which might play a role in the decision to continue treatments during pregnancy. According to our study pregnancy appears to have a significant influence on drug prescriptions of different pharmacological treatments for psoriasis.

Keyphrases

pregnant women
pregnancy outcomes
drug induced
adverse drug
preterm birth
decision making
atopic dermatitis
human health